Atomistry » Fluorine » PDB 8dxh-8e72 » 8e1a
Atomistry »
  Fluorine »
    PDB 8dxh-8e72 »
      8e1a »

Fluorine in PDB 8e1a: Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors

Protein crystallography data

The structure of Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors, PDB code: 8e1a was solved by N.Lallous, H.Li, M.Radaeva, K.Dalal, E.Leblanc, F.Ban, F.Ciesielski, B.Chow, M.Morin, K.Singh, P.S.Rennie, A.Cherkasov, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 40.00 / 1.20
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 54.953, 65.762, 69.128, 90, 90, 90
R / Rfree (%) 12.4 / 15.1

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors (pdb code 8e1a). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors, PDB code: 8e1a:

Fluorine binding site 1 out of 1 in 8e1a

Go back to Fluorine Binding Sites List in 8e1a
Fluorine binding site 1 out of 1 in the Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1001

b:12.2
occ:1.00
FAA A:3E01001 0.0 12.2 1.0
CAB A:3E01001 1.4 11.8 1.0
CAC A:3E01001 2.3 12.1 1.0
CAF A:3E01001 2.4 11.7 1.0
CAE A:3E01001 2.7 14.5 1.0
OAD A:3E01001 2.7 12.2 1.0
O A:HOH1224 3.3 13.4 1.0
CB A:MET749 3.3 9.0 1.0
NH2 A:ARG752 3.4 9.9 1.0
CG A:MET749 3.4 9.2 1.0
CD1 A:PHE764 3.4 8.6 1.0
CAI A:3E01001 3.6 11.6 1.0
CAG A:3E01001 3.6 11.2 1.0
O A:MET745 3.8 7.8 1.0
CAH A:3E01001 4.1 11.4 1.0
CE1 A:PHE764 4.1 9.2 1.0
CA A:PHE764 4.3 8.4 1.0
O A:PHE764 4.3 8.4 1.0
CG A:PHE764 4.3 7.6 1.0
CB A:MET745 4.3 7.9 1.0
C A:MET745 4.4 7.5 1.0
CB A:PHE764 4.4 8.5 1.0
CA A:MET749 4.6 7.6 1.0
CZ A:ARG752 4.7 9.0 1.0
C A:PHE764 4.8 7.3 1.0
CA A:MET745 4.8 7.9 1.0
CE A:MET749 4.8 13.1 1.0
CAJ A:3E01001 4.9 11.0 1.0
CD2 A:LEU707 4.9 9.3 1.0
SD A:MET749 4.9 9.8 1.0
N A:MET749 5.0 8.2 1.0

Reference:

M.Radaeva, H.Li, E.Leblanc, K.Dalal, F.Ban, F.Ciesielski, B.Chow, H.Morin, S.Awrey, K.Singh, P.S.Rennie, N.Lallous, A.Cherkasov. Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors. Cells V. 11 2022.
ISSN: ESSN 2073-4409
PubMed: 36139361
DOI: 10.3390/CELLS11182785
Page generated: Wed Jul 16 03:33:46 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy